Univariate COX analysis revealed that increased CHST11 mRNA expression and advanced TNM stage in HCC predicted worse survival outcome (CHST11: hazard ratio [HR] = 1.146, 95% CI = 1.031–1.274, p = 0.012; TNM stage: HR = 1.571, 95% CI = 1.127–2.188, p = 0.008; Figure 2D). Here, CHST11 is linked to hepatocellular carcinoma.